ARTICLE | Company News
Cambrex, Zeria deal
July 11, 2011 7:00 AM UTC
Cambrex granted Zeria's Tillotts Pharma AG subsidiary exclusive, worldwide rights to use Cambrex's mesalamine-based technology to develop and commercialize products for the treatment of inflammatory b...